Compare iShares MSCI India ETF (INDA) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI India ETF vs Inovio Pharmaceuticals Inc — how do they compare? iShares MSCI India ETF trades at $48.16, while Inovio Pharmaceuticals Inc trades at $1.08 (market cap $90.50M). The key difference: iShares MSCI India ETF is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| INDA | INO | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $55.29 | $2.87 |
52-Week Low | $45.42 | $1.05 |
Market Cap | — | $90.50M |
Enterprise Value | — | $61.51M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares MSCI India ETF
INDA tracks the MSCI India Index, providing broad exposure to large and mid-cap companies in the Indian stock market. It is structurally dominated by the financials, information technology, and energy sectors, serving as a core instrument for investors seeking a single-country view of India's long-term economic growth.
Read more on INDA →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
